Celltrion has submitted an application to obtain approval for CT-P16, a biosimilar of Roche's Avastin (ingredient: bevacizumab), for colorectal cancer treatment in the U.S. and Korea.The company completed global clinical trials of CT-P16 at 150 cites in 20 countries in Europe, South America, and Asi
The government said Friday it would secure sufficient healthcare capacity first to move to the “live-with-covid” system from November.It was the first time that the government officially set its timeline to shift to the relaxed quarantine system, in which most restrictions are eased with officials f
Global pharmaceutical companies’ investment in R&D in Korea has continued to rise for the fifth consecutive year in 2020, an industry group report showed.The number of early clinical trials and studies of cancer and rare diseases increased significantly, and employment for R&D also expanded steadily
Merck’s oral antiviral treatment for Covid-19, molnupiravir, has reportedly shown potential efficacy on the variants of the Covid-19 virus, causing Korean companies to speed up efforts to develop similar oral medicines.Merck, or MSD in the U.S. and Canada, said Wednesday its experimental Covid-19 th
Takeda Korea said its ovarian cancer treatment Zejula would receive expanded health insurance coverage as maintenance therapy for breast cancer (BRCA) susceptibility gene-mutated ovarian cancer patients who responded to first-line platinum-based therapy from Friday.Under the latest revision, the gov
Korea Research Institute of Chemical Technology (KRICT) said Thursday that an HIV treatment candidate developed by its team has been transferred to a domestic company and began sales in China as a new drug.The institute said that the drug candidate, once could have been thrown away, was transferred
Vuno said that it has signed a contract to install VUNO Med-Chest X-ray, an artificial intelligence (AI)-based chest X-ray image reading solution, on Samsung Electronics' premium ceiling-mounted digital X-ray imaging equipment GC85A.The contract follows a deal in June to supply Vuno Med Chest X-ray
The Rehabilitation Engineering Research Center (RERC), affiliated with the Korea Workers’ Compensation & Welfare Service, said it would participate in a civil-military partnership program to help people with gait disorders walk more easily.The RERC has been selected as the lead research institute to
Bukwang Pharmaceutical said it would withdraw its plan to develop its antiviral drug Levovir (clevudine) as a Covid-19 treatment.The company said it had no intention to work on the drug again.Industry watchers said Bukwang’s failure to achieve the primary endpoint in a recent trial made it almost im
The government said Thursday that it would provide various support for companies to develop at least one homegrown mRNA Covid-19 vaccine by 2023.Next year, it will spend 526.5 billion won ($444 million) to help drugmakers conduct clinical and non-clinical studies while pre-purchasing homegrown Covid
GenBody said Thursday that the U.S. Food and Drug Administration granted emergency use authorization (EUA) for its GenBody COVID-19 antigen (Ag), a rapid diagnostic kit for Covid-19 in a nasal sampling format on Sep. 24.GenBody COVID-19 Ag provides diagnosis results within 15 minutes and can prevent
EOFlow has made the first shipment of the world's second wearable insulin pump, EOPatch, to the European market.EOPatch is a new-generation wearable insulin pump that succeeded in commercialization, solving the problem of long infusion lines in existing pumps, which had limited free movement for use
JW Pharmaceutical has begun marketing Livalozet, the first domestic combination drug of pitavastatin and ezetimibe, for treating dyslipidemia.The company said its dyslipidemia therapy doses are available in 2 or 4 milligrams of pitavastatin with 10 mg of ezetimibe. Medical professionals and patients
The government said it would bring up medical scientists specializing in AI and big data for clinical research and new drug development.Bang Young-sik, director of the Healthcare Data Promotion Division at the Ministry of Health and Welfare, presented a blueprint for a health data-based industry at
Korean pharmaceutical companies are increasingly jumping into the Avastin (bevacizumab) biosimilar market.Samsung Bioepis won local approval for its Avastin biosimilar in March, and Pfizer Korea, in May. Celltrion is the latest player to enter the Avastin biosimilar market.In a regulatory filing on
Roche Diagnostics Korea said Thursday that it has appointed Kit Tang, the former general manager of Roche Diagnostics Taiwan, as its new GM effective on Oct. 1."General Manager Tang is an expert in the field of in-vitro diagnostics with over 20 years of experience in the diagnostic industry," the co
Chong Kun Dang said that the Ministry of Health of Ukraine has approved the company to conduct a phase 3 clinical trial of Covid-19 drug candidate, Nafabeltan (ingredient: nafamostat).Ukraine is the first foreign country to authorize Chong Kun Dang’s phase 3 study following the approval granted by t
Myongji Hospital said it would transfer advanced medical technology to Uzbekistan.Myongji Hospital and the Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology of Uzbekistan agreed Wednesday to cooperate in broad fields, such as medical technology, training of medical
The state-run Korea Dementia Research Center (KDRC), founded last year, began to build a support system to help companies actively conduct research and development of dementia treatment.On Wednesday, the Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) and KDRC held a seminar on
Asia-Pacific (APAC) medical and pharmaceutical fields have increased their presence globally in recent years. Such exponential growth has made the region one of the major players in the world, with various global pharmaceutical companies targeting the area as their future growth engine. Against this